66--Purchase Order for One (1) Dual MRI Infusion Syste

The National Institutes of Health, through the Office of Logistics and Acquisition Operations, has issued a non-competitive combined synopsis and solicitation for the procurement of one Dual MRI Infusion System to replace an aging MRI-compatible pump that is no longer supported beyond January 2025. This acquisition, conducted under FAR 12.603 as a commercial item purchase, is designated for small business set-aside under NAICS code 339112 and issued as solicitation number 75N98026Q00564. The required equipment includes the Iradimed Dual MRI Infusion System with a non-magnetic design rated for placement up to the 10,000 Gauss line, a wireless remote control, mounting hardware, dual charge power kit, non-magnetic IV pole, and associated accessories, all intended for seamless integration into the existing MRI system at NIH/NIMH in Bethesda, Maryland with minimal training required. The offeror must provide a completed FAR 52.212-3 certification, valid UEI and TIN, active SAM registration, and business size certification, along with detailed pricing, delivery terms, F.O.B. point, and delivery timeline post-award. The contract award will be based on best value, considering price along with technical capability, past performance, delivery schedule, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency. Responses are due by June 19, 2026, at 5:30 pm EDT and must be submitted via the SAM.gov webportal referencing the solicitation number. Delivery is required FOB destination at the specified NIH/NIMH location, though no specific delivery date is fixed beyond a multiple delivery window. The contract will incorporate all applicable FAR clauses in effect through FAC 2026-01, including FAR 52.212-4 and 52.212-5, which govern terms and conditions for commercial items. No inspection, packaging, or special contract requirements are detailed, and the total contract value is not specified. The point of contact for inquiries is Brittany May, and the issuing office is located in Bethesda, Maryland.